Michael Fitzhugh

The FDA is seeking to accelerate personalized medicine drive and improve service to small business with its new plan.

The complexity of the U.S. health care system and lackluster follow-through have slowed the pace at which innovations are taking hold despite the rapid evolution of technologies and supportive federal policies.

President proposes trimming data exclusivity and nixing pay-for-delay.

GE partners with venture capitalists to draw fresh ideas and new collaborations.

HHS aims to improve individual's access to their own data, while safeguarding it too.

Trial of WellDoc system shows positive results, but potential barriers remain.

As pharmaceutical giants cut their budgets for discovery, external partners are picking up the slack.

Mobile apps for the diagnosis, prevention and treatment of disease will be treated and regulated like medical devices.

Google was among the companies to rush into the world of digital health, but it's closing the doors on its Google Health site at the beginning of 2012.

Drug companies are allowed use your prescription records to tailor their drug pitches to you. The U.S. Supreme Court just overturned a Vermont law that made that sort of data mining illegal.

Genzyme's shares leaped after Sanofi's board authorized its chief executive to bid up to $70 per share for the drug maker, though Genzyme may hold out for as much as $75 per share. A slew of biotechs reported earnings, and upbeat clinical trial data boosted some stocks.